Corporate Profile

We are a clinical stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation.

More
ANAB (Common Stock) $22.06 Stock is Up 0.77 (3.62%)08/18/17 4:00 p.m. ET
Stock chart for: ANAB.O.  Currently trading at $22.06 with a 52 week high of $30.71 and a 52 week low of $15.17.
Data provided by Nasdaq. Minimum 15 minutes delayed.




Upcoming Events


  |   |   |   |   |